FDA Focusing On Ephedra Solution Within DSHEA Parameters, McClellan Says
This article was originally published in The Tan Sheet
Executive Summary
FDA is committed to operating within the confines of the Dietary Supplement Health & Education Act rather than seeking changes in the law as it prepares for action on ephedra-containing dietary supplements, according to FDA Commissioner Mark McClellan, MD/PhD